BEHANDLUNG METASTASIERTER TUMORE

European patent · EP1845990 · Deleted

Register entry

Publication number
EP1845990
Application number
EP06733986
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jan 27, 2006
Published
Oct 24, 2007
Granted
Sep 28, 2011
Deleted
Jan 31, 2016
Reason
Annual fee unpaid
IPC classes
A61K 31/497 (2006.01)
A61P 35/00 (2006.01)
Priority
US 647568 P 27.01.2005
US 669245 P 06.04.2005
US 722053 P 29.09.2005
PCT application
PCT/US2006/002979 27.01.2006
PCT publication
WO2006/081445 03.08.2006
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 24, 2016

    Deleted, fee unpaid

    Published in Swissreg on 24.08.2016

  2. Sep 28, 2011

    Granted

    Published in Swissreg on 28.09.2011

Parties

Holder

Novartis Vaccines and Diagnostics, Inc.

Intellectual Property - R440 P.O. Box 8097, Emeryville, CA 94662-8097, US

Inventor

LOPES DE MENEZES, Daniel, c/o Chiron Corporation

Emeryville, CA 94662-8097, US

HEISE, Carla, c/o Chiron Corporation

Emeryville, CA 94662-8097, US

XIN, Xiaohua, c/o Chiron Corporation

Emeryville, CA 94662-8097, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.